We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

157 hedge funds and large institutions have $282M invested in Definium Therapeutics in 2024 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 51 increasing their positions, 29 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more call options, than puts

Call options by funds: $4.76M | Put options by funds: $2.67M

76% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 29

38% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 21

4% more funds holding

Funds holding: 151 → 157 (+6)

3.03% more ownership

Funds ownership: 57.79% → 60.82% (+3%)

6% less capital invested

Capital invested by funds: $299M → $282M (-$17.7M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
157
Holders Change
+6
Holders Change %
+3.97%
% of All Funds
2.25%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
29
Increased
51
Reduced
29
Closed
21
Calls
$4.76M
Puts
$2.67M
Net Calls
+$2.1M
Net Calls Change
-$8.54M

Top Buyers

Rank Fund Capital Flow
1
Blackstone Inc
Blackstone Inc
New York
+$14M
2
DCM
Driehaus Capital Management
Illinois
+$9.43M
3
TLP
Tri Locum Partners
New York
+$8.91M
4
DTC
Deep Track Capital
Connecticut
+$6.69M
5
OCA
Octagon Capital Advisors
New York
+$6.02M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$7.27M
2
Two Sigma Investments
Two Sigma Investments
New York
-$2.81M
3
ABG
Ally Bridge Group
New York
-$1.23M
4
IC
Ikarian Capital
Texas
-$696K
5
AGM
Alpine Global Management
New York
-$492K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
101
Tower Research Capital (TRC)
New York
$23K +$7.14K +1,027 +34%
AB
102
Amalgamated Bank
New York
$14K – – –
JIP
103
Jaffetilchin Investment Partners
Florida
$13.6K +$16.6K +2,389 New
CA
104
Crewe Advisors
Utah
$11.4K – – –
Carson Wealth (CWM LLC)
105
Carson Wealth (CWM LLC)
Nebraska
$9K +$1.63K +235 +19%
National Bank of Canada
106
National Bank of Canada
Quebec, Canada
$8.36K -$1.89K -272 -16%
IA
107
IFP Advisors
Florida
$5.69K -$6.96K -1,000 -50%
FFA
108
Farther Finance Advisors
California
$5.24K +$5.71K +821 +821%
Russell Investments Group
109
Russell Investments Group
United Kingdom
$4.62K +$5.65K +812 New
VWM
110
Venturi Wealth Management
Texas
$4.1K +$5.01K +721 New
PA
111
Parallel Advisors
California
$4.09K – – –
NS
112
NBC Securities
Alabama
$3K – – –
SPIA
113
Steward Partners Investment Advisory
New York
$2.85K +$3.48K +500 New
HI
114
Harbour Investments
Wisconsin
$2.6K – – –
CIBC Private Wealth Group
115
CIBC Private Wealth Group
Georgia
$2.41K – – –
NL
116
NVWM LLC
Pennsylvania
$2.37K – – –
TIM
117
Tortoise Investment Management
New York
$2.28K – – –
Northwestern Mutual Wealth Management
118
Northwestern Mutual Wealth Management
Wisconsin
$2.27K +$97 +14 +4%
AWM
119
Avior Wealth Management
Nebraska
$2.26K – – –
CA
120
Continuum Advisory
Idaho
$2K +$1.52K +219 +1,095%
GI
121
GAMMA Investing
California
$1.04K +$1.27K +183 New
NA
122
NewEdge Advisors
Louisiana
$842 – – –
AFG
123
Albion Financial Group
Utah
$752 – – –
TVWM
124
Tower View Wealth Management
Wisconsin
$569 +$696 +100 New
CPG
125
Cornerstone Planning Group
New Jersey
$497 +$536 +77 New
3 4
5
6 7

DFTX Hedge Fund Activity: Q3 2024 in Review

157 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2024, worth a combined $282M — down 5.9% from $299M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new DFTX positions and 21 closed out — a net gain of 8 holders — while 51 added to existing stakes and 29 trimmed.

The largest buyer was Blackstone Inc, adding an estimated $14M. The largest seller was Artal Group, exiting entirely with an estimated $7.27M sold.

  • 157 institutional investors held Definium Therapeutics (DFTX) as of Q3 2024, up from 151 in Q2 2024.
  • Funds reported $282M of Definium Therapeutics stock for Q3 2024, down 5.9% quarter-over-quarter.
  • 29 funds opened new Definium Therapeutics positions in Q3 2024 and 21 closed out, a net change of +8 holders.
  • The largest Definium Therapeutics buyer in Q3 2024 was Blackstone Inc, an estimated $14M added.
  • The largest Definium Therapeutics seller in Q3 2024 was Artal Group, an estimated $7.27M sold.

Based on aggregated 13F filings for Q3 2024.